IDH1 and neoplasm: Similarly, in a cohort of untreated, molecularly characterized adult-type diffuse glioma IDH-mutant patients, tumor diameter >6 cm and midline crossing were identified as independent prognostic factors for PFS among the items included in the EORTC score, highlighting the major impact of tumor size on risk assessment (41).